Judicious use of medication in children;Uso judicioso de medicamentos em crianças

Jornal de Pediatria

Volumn 79, Issue SUPPL. 1, 2003, Pages

  Bricks, Lucia Ferro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHYLLINE; AMOXICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIPYRETIC AGENT; ANTITUSSIVE AGENT; ASCORBIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOOXYGENASE 2 INHIBITOR; DECONGESTIVE AGENT; DICLOFENAC; EXPECTORANT AGENT; IBUPROFEN; INDOMETACIN; KETOPROFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MUCOLYTIC AGENT; NEDOCROMIL; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; THEOPHYLLINE; UNINDEXED DRUG; VASOCONSTRICTOR AGENT;

ACUTE RESPIRATORY TRACT DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASTHMA; CHILD; CHILD CARE; DRUG EFFICACY; DRUG INDICATION; DRUG TOXICITY; DRUG USE; HUMAN; MEDLINE; REVIEW; TREATMENT INDICATION;

EID: 0038177453     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-75572003000700012     Document Type: Review

References (44)

1. Bricks LF, Leone C. Terapêutica das infecções respiratórias agudas: problemas e desafios na melhoria das prescrições médicas, In: Benguigui Y, editor. Investigações operacionais sobre o controle das infecções respiratórias agudas (IRA). Washington, D.C.: OPAS; 1997.p.101-8.
2. Bricks LF, Sih T, Medicamentos controversos em otorrinolaringologia. J Pediatr (Rio J) 1999;75:11-22.
3. Bricks LF, Berezin E, Silveira L. Uso e abuso de antibióticos em IRA e resistência bacteriana. In: Bricks LF, Cervi MC. Atualidades em Doenças Infecciosas. São Paulo: Atheneu; 2002.p.197-214.
4. Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis 1993;12:115-20.
5. Gadomski AM. Rational use of over-the-counter medications in young children. JAMA 1994;272:1063-4.
6. Kogan MD, Pappas G, Yu SM, Kotelchuck M. Over-the-counter medications use among US preschool-age children. JAMA 1994; 272:1025-30.
7. Smith MBH, Feldman W. Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. JAMA 1993;269:2258-63.
8. Dowell SF, Marcy M, Phillips WR, Phillips W, Gerber MA. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 1998;101:163-5.
9. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999;96:1152-6.
10. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002;8:1-9.
11. Carbon C, Isturiz R. Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to betalactams. Drugs 2002;62:1289-94.
12. Dowell SF, Marcy M, Phillips WR, Phillips W, Gerber MA. Otitis media - principles of judicious use of antimicrobial agents. Pediatrics 1998;10:165-71.
13. DelMar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A metaanalysis. BMJ 1997;314:1526-29.
14. Rosenfeld RM. An evidence-based approach to treating otitis media. Pediatr Clin North Amer 1996;43:1165-81.
15. Hoppe JE, Koster S, Bootz F, Niethammer D. Acute mastoiditis - relevant once again. Infection 1994;22:178-82.
16. Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-resistant streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9.
17. Cohen R, Navel M, Grumberg J, Boucherat M, Geslin P, Derriennic M, et al. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J 1999;18:403-9.
18. Schrag S, Pena C, Fernandez J, Sanchez J, Gomez V, Perez E, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001;286:49-56.
19. Schwartz B, Marcy M, Phillips WR, Gerber MA, Dowell SF. Pharyngitis - principles of judicious use of antimicrobial agents. Pediatrics 1998;101:171-4.
20. O'Brien KL, Dowell SF, Schwartz B, Marcy M, Phillips WR, Gerber MA. Acute sinusitis - principles of judicious use of antimicrobial agents. Pediatrics 1998;101:174-7.
21. Morris P, Leach A. Antibiotics for persistent nasal discharge (Rhinosinusitis) in children. Cochrane Database Syst Rev 2002;(4):CD001094.
22. Rosenstein N, Phillips WR, Gerber MA, Marcy M, Schwartz B, Dowell SF. The common cold - principles of judicious use of antimicrobial agents. Pediatrics 1998;101:181-4.
23. Spector SL. The common cold: current therapy and natural history. J Allergy Clin Immunol 1995;95:1133-8.
24. Wise R. Antibiotics for the uncommon cold. Lancet 1996; 347:1499.
25. Brown JC, Bundy DG. Should we advise parents to administer over the counter cough medicines for acute cough? Systematic review of randomized controlled trials. J Pediatr 2002;141:446.
26. Davies MJ, Fuller P, Picciotto A, McKenzie SA. Persistent nocturnal cough: randomized controlled trial of high dose inhaled corticosteroid. Arch Dis Child 1999;81:38-44.
27. Hutton N, Wilson MM, Mellitis E. Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized controlled trial. J Pediatr 1991; 118:125-30.
28. Lindquist M, Edwards R. Risks of non-sedating antihistamines. Lancet 1997;349:1322.
29. Luks D, Anderson MR. Antihistamines and the common cold. A review and critique of the literature. J Gen Intern Med 1996; 11:250-4.
30. Clark S. Dangers of non-sedating antihistamines. Lancet; 1997;349:1268.
31. Cantekin EI, Mandel EM, Bluestone CD, Rockette HE, Paradise JL, Stoll SE, et al. Lack of efficacy of a decongestantantihistamine combination for otitis media with effusion ("secretory" otitis media) in children. N Engl J Med 1983; 308:297-301.
32. van der Merwe J, Wagenfeld DJH. The negative effects of mucolytics in otitis media with effusion. S Afr Med J 1987;72: 625-6.
33. Butler CC, van der Voort JH. Oral or topic nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2002;(4):CD001935.
34. Consenso Brasileiro no Manejo da Asma. J Pneumol 2002;28 Supl 1:1-28.
35. McKenzie AS, Bush A. Difficult asthma in children. Thorax 2002;57:915-20.
36. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 1995;95:1097-110.
37. Meltzer EO, Tyrell RJ, Rich D, Wood CC. A pharmacological continuum in the treatment of rhinorrhea: the clinician as economist. J Allergy Clin Immunol 1995;95:1147-52.
38. Bricks LF. Analgésicos antitérmicos e antiinflamatórios nãohormonais: controvérsias sobre sua utilização em crianças. Pediatria (São Paulo) 1998;20:230-46.
39. Bricks LF. Uso de antiinflamatórios não hormonais em crianças com doenças virais vs. risco potencial de síndrome de Reye e doenças invasivas graves pelo Streptococcus do grupo A. Pediatria (São Paulo) 2000;22:35-43.
40. McGovern MC, Glasgow JTF, Stewart MC. Reye's syndrome and aspirin: lest we forget. BMJ 2001;322:1591-2.
41. American Academy or Pediatrics. Acetaminophen toxicity in children. Pediatrics 2001;108:1020-4.
42. Levy S, Volans G. The use of analgesics in patients with asthma. Drug Safe 2001;24:829-41.
43. Berde CB, Sethna NF. Drug therapy: analgesics for the treatment of pain in children. N Engl J Med 2002;347:1094-103.
44. Russel F, Mulholland K. Prevention of otitis media by vaccination. Drugs 2002;62:1441-5.